CG
CME GROUP INC. (CME)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 delivered solid growth: revenue $1.53B (+6% YoY), GAAP diluted EPS $2.40 and adjusted diluted EPS $2.52; clearing & transaction fees were $1.23B, with average rate per contract (RPC) up to $0.701 from $0.666 in Q3 .
- Strong mix: Market Data revenue rose to $182M (+9% YoY), non‑U.S. ADV 7.6M (+5% YoY); commodities remained a growth engine and buy‑side participation increased, with management highlighting ~$60B/day in margin savings across asset classes .
- 2025 outlook: adjusted operating expenses (ex‑license fees) ~$1.65B, capex ~$90M, tax rate 22.5–23.5%, pricing actions expected to add ~2–2.5% to pretax income; plus a 9% dividend increase to $1.25/share .
- Potential catalysts: securities clearing application advancing; retail distribution ramp (e.g., Robinhood); fee changes (transaction, data, collateral surcharge) and Google Cloud migration supporting product and data innovation .
What Went Well and What Went Wrong
What Went Well
- Broad-based performance with Q4 revenue $1.53B, operating income $947M, adjusted EPS $2.52; Market Data revenue $182M (+9% YoY) and RPC rose to $0.701 on mix shift to higher-priced commodities and less volume tiering .
- Retail and buy-side momentum: new client acquisition drove meaningful volume and revenue; management cited ~2/3 of $1B NCA revenue over five years coming from retail and buy-side commodity options strength (options volumes up 29% YoY in 2024) .
- Capital efficiencies: management reiterated unmatched margin savings — ~$20B/day in interest rates and ~$60B/day across all six asset classes — supporting client stickiness and competitiveness .
What Went Wrong
- Non-operating items remained a headwind: “Other non-operating income (expense)” was -$837.5M in Q4 (vs -$961.2M Q4’23), tempering net operating strength .
- Adjusted expense pressure from cloud migration: Q4 adjusted expenses were $520M (incl. ~$22M Q4 cloud spend), with 2025 guidance including ~$115M migration costs; margin impact must be monitored .
- Securities clearing timeline uncertainty: while the application is progressing, management acknowledged potential delays in broader clearing mandates and regulatory processes, reducing near-term visibility .
Financial Results
Revenue, EPS, Operating Income (GAAP vs Adjusted)
Revenue Breakdown
KPIs: ADV by Product Line (Futures & Options), Non-U.S. ADV, RPC
Non-GAAP Adjustments (Q4 2024)
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “In 2024, CME Group had its best year ever… Our Q4 performance also was very strong, delivering a 6% increase in revenue, adjusted net income and adjusted earnings per share.” — Terry Duffy, Chairman & CEO .
- “Our customers are now saving approximately $60 billion per day across all six asset classes.” — Terry Duffy .
- “We expect total adjusted operating expenses… to be approximately $1.65 billion. Total capital expenditures are expected to be approximately $90 million, and the adjusted effective tax rate… 22.5%–23.5%.” — Lynne Fitzpatrick, CFO .
- “In aggregate, the fee changes and cash minimum could add 2% to 2.5% to pretax income, assuming similar volume and collateral levels.” — Lynne Fitzpatrick .
Q&A Highlights
- Retail rollout and strategy: Robinhood futures in phased rollout; broad retail partner base (~100 globally); retail NCA +23% YoY; management expects continued blurring of institutional vs retail profiles with tech/AI tools .
- Capital allocation: Dividend raised to $1.25; buyback program described as opportunistic alongside regular and variable dividends .
- Pricing mechanics: 1%–1.5% transaction fee uplift includes incentives; collateral surcharge impact depends on customer choices (other revenue vs non‑op income) .
- Securities clearing and cross‑margin: Application with SEC published; benefits to capital efficiency noted; partnership with FICC expanding; acknowledges potential timeline delays .
- Cloud migration spend: Q4 migration ~$22M; FY’24 ~$85M; FY’25 ~$115M; focus on non‑latency apps and building additional client data capabilities .
- BrokerTec trends: January ADV up 29% MoM; market share improved; repo complex record ADV and new modalities (curve spreads, butterflies) gaining traction .
Estimates Context
- Wall Street consensus via S&P Global (Capital IQ) was unavailable at the time of this report due to data request limits; we were unable to present Q4 comparisons vs consensus for EPS, revenue, or EBITDA. Values normally retrieved from S&P Global will be added upon access restoration.
Key Takeaways for Investors
- Q4 print was resilient with solid YoY growth and improved RPC; adjusted EPS of $2.52 underscores earnings quality despite non‑op headwinds .
- 2025 pricing actions and collateral policies are measurable earnings levers (~2–2.5% pretax uplift), offering visibility independent of market volatility .
- Retail and buy-side secular engagement (commodities and options) supports mix and RPC; watch for incremental distribution milestones (e.g., Robinhood ramp) .
- Regulatory developments (securities clearing) and expanding cross‑margining with FICC are strategic catalysts that can deepen client stickiness and capital efficiencies .
- Dividend increase (+9%) plus potential opportunistic buybacks reinforce capital return; monitor non‑op items and cloud migration spend trajectory for margin implications .
- Cloud/AI partnership with Google should enable product/data innovation and client analytics over time; near‑term spend steps up in 2025 but long‑term ROI can be attractive .
- Near-term trading: pricing tailwinds, commodity/options strength, and macro/geopolitical uncertainty favor elevated activity across complexes; focus on rate, commodity, and crypto contracts as tactical vehicles .
Sources: SEC 8-K (Item 2.02) and Exhibit 99.1 release for Q4 2024 **[1156375_0001156375-25-000007_cme-20250212.htm:0]** **[1156375_0001156375-25-000007_cme-20250212.htm:1]** **[1156375_0001156375-25-000007_exhibit991123124.htm:0]** **[1156375_0001156375-25-000007_exhibit991123124.htm:7]** **[1156375_0001156375-25-000007_exhibit991123124.htm:8]** **[1156375_0001156375-25-000007_exhibit991123124.htm:9]**; CME press release Q4 2024 **[1156375_20250212AQ17346:0]**-**[1156375_20250212AQ17346:4]**; Q4 earnings call transcripts **[1156375_CME_3415528_0]**-**[1156375_CME_3415528_24]** **[1156375_1973106_0]**-**[1156375_1973106_17]**; Prior quarters Q3 press release/transcript **[1156375_20241023AQ37794:0]**-**[1156375_20241023AQ37794:4]** **[1156375_CME_3403367_0]**-**[1156375_CME_3403367_26]**; Q2 press release/transcript **[1156375_20240724AQ68226:0]**-**[1156375_20240724AQ68226:5]** **[1156375_CME_3394105_0]**-**[1156375_CME_3394105_31]**; Dividend press release **[1156375_20250206CG13127:0]**.